Circulating autotaxin (ATX) levels have been reported to correlate with liver inflammation activity and liver fibrosis severity in patients with non-alcoholic fatty liver disease (NAFLD). Here, ENPP2 is linked to metabolic dysfunction-associated steatotic liver disease.